The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm.

Alembic Pharmaceuticals climbed 3.07% to Rs 930.50 after the company said it has received final USFDA approval for its ANDA for Diltiazem Hydrochloride tablets.

The company said this development further strengthens its US generics business and adds depth to its offerings in the cardiovascular segment.

Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Diltiazem Hydrochloride Tablets USP.

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg: Our Bureau, Mumbai Monday, November 17, 2025, 13:30 Hrs [IST] Alembic ...

Stocks like Max Healthcare Institute, V2 Retail, Narayana Hrudayala, GMR Power and Urban Infra, Ashoka Buildcon, Websol ...

On Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride ...

Explore the latest updates on Lupin, Alembic Pharma, Maruti Suzuki, and Ola Electric's significant market moves.

Vadodara: Pharma firm Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New ...

Real-time updates on ALEMBIC PHARMA share price. Check out the detailed analysis of the company in this live blog.

Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dexlansoprazole ...